Reduction of bone density: An effect of gonadotropin releasing hormone analogue treatment in central precocious puberty
- 1 September 1993
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 152 (9) , 717-720
- https://doi.org/10.1007/bf01953983
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin‐releasing hormone analogue treatmentActa Paediatrica, 1993
- Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiencyThe Journal of Pediatrics, 1993
- Osteopenia in Men with a History of Delayed PubertyNew England Journal of Medicine, 1992
- REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMENClinical Endocrinology, 1988
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- Growth, Growth Hormone and Sex Steroid Secretion in Girls with Central Precocious Puberty Treated with a Gonadotrophin Releasing Hormone (GnRH) AnalogueActa Paediatrica, 1988
- LHRH ANALOGUES AND BONE LOSSThe Lancet, 1987
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept.Archives of Disease in Childhood, 1982
- Bone mineral status in growth hormone deficiencyThe Journal of Pediatrics, 1980